
DaVita Kept Dialysis Running. Its Stolen Laboratory Data Had a Longer Afterlife.
New financial filings clarify the cost of the 2025 ransomware attack—and why restoring treatment systems did not close the breach’s consequences.
The financial traces of an attack on DaVita are still visible in its 2026 accounts. They require careful reading: a reference to roughly $12 million in the latest quarterly filing describes expenses incurred in the third quarter of 2025, not a new bill for an attack in 2026. The distinction separates the continuing disclosure of a corporate breach from evidence of a continuing intrusion.
The more revealing number appears in the dialysis company’s 2025 annual report, published in 2026. DaVita recorded approximately $1 million in patient-care charges and $24.2 million in administrative expenses related to remediation and restoring systems during that year. Together, those categories amount to about $25.2 million. They exclude the effect of business interruption. They are therefore a defined expense measure, not a complete valuation of the attack.
That accounting boundary matters because this was an intrusion into a company whose information systems sit alongside recurring, essential treatment. Reuters reported in August 2025 that a federal health-department listing put the number affected at 2.7 million people. DaVita told the news agency that its teams had maintained the uninterrupted delivery of critical care. A large data breach and continued treatment can both be true; the record does not justify turning the number of affected records into a count of missed dialysis sessions.
The breach notice supplies a different clock from the date of public disclosure. In its August 5 letter filed with Montana’s Department of Justice, DaVita said the incident began on March 24, 2025, and the unauthorized party was blocked on April 12, the day the company discovered it. The affected servers were primarily at its laboratories. By about June 18, the company had determined that the recipient’s information was potentially involved.
The information varied by person. The notice identified possible exposure of demographic and insurance details, Social Security numbers, clinical information and dialysis laboratory results; some records also contained tax identifiers or, in limited cases, check images. These were possible categories across the affected population, not a claim that every person lost every category. The letter also said there was no evidence at that time that the recipient’s information had been used for fraud. That assurance has a date and a scope; it is not proof that stolen records carry no future risk.
For some recipients, the corporate connection was less obvious than a visit to a dialysis center. DaVita’s incident website explains that its laboratory subsidiary processes results for other providers and practices. Someone could therefore receive a breach letter without having been treated at DaVita. The service relationship had widened the pool of people whose information the company held.
That is the distinctive exposure of a medical-services business with a laboratory arm. The organization defending a database may be different from the provider a patient recognizes. A patient’s practical relationship with one clinic does not reveal every company through which a result or identifying record travels. DaVita’s explanation establishes that relationship here; it does not establish that those outside providers were themselves penetrated.
MedTech Dive’s contemporaneous reporting recorded the claim of responsibility by the Interlock ransomware group, attributing that information to specialist reporting. A criminal group’s claim is not a judicial finding about the perpetrators. The same report described a business disruption affecting billing, collection and patient census, alongside continued care. Those separate consequences explain why a company can restore systems while the commercial effects take longer to settle.
The latest September 2026 quarterly filing still uses the 2025 incident when explaining year-on-year expenses and adjusted operating results. It records approximately $1 million in patient-care costs and $24 million in administrative charges for the first nine months of 2025. These comparative figures should not be added to the annual total as another loss. Nor does their appearance prove a fresh breach.
In its August 2025 update, DaVita said the major affected network servers and systems had been restored securely. The public record supports a narrower, durable conclusion: treatment continuity did not prevent a consequential theft of corporate-held medical information, and restoration did not make the incident disappear from financial reporting. The company’s recovery and the patients’ loss of control over their information operate on different timelines.
Compiled November 16, 2026. Records and findings keep the dates stated in their sources; each link in the text opens the document it relies on.